nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Dactinomycin—testicular cancer	0.167	0.263	CbGbCtD
Riluzole—ABCG2—Carboplatin—testicular cancer	0.112	0.177	CbGbCtD
Riluzole—ABCG2—Cisplatin—testicular cancer	0.0958	0.151	CbGbCtD
Riluzole—ABCG2—Etoposide—testicular cancer	0.0941	0.148	CbGbCtD
Riluzole—ABCG2—Doxorubicin—testicular cancer	0.0642	0.101	CbGbCtD
Riluzole—ABCG2—Methotrexate—testicular cancer	0.0622	0.0981	CbGbCtD
Riluzole—CYP1A2—Etoposide—testicular cancer	0.0388	0.0612	CbGbCtD
Riluzole—Abdominal pain—Etoposide—testicular cancer	0.000149	0.000408	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—testicular cancer	0.000149	0.000408	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—testicular cancer	0.000149	0.000408	CcSEcCtD
Riluzole—Haemorrhage—Epirubicin—testicular cancer	0.000149	0.000407	CcSEcCtD
Riluzole—Hepatitis—Epirubicin—testicular cancer	0.000149	0.000407	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—testicular cancer	0.000149	0.000407	CcSEcCtD
Riluzole—Hypoaesthesia—Epirubicin—testicular cancer	0.000148	0.000405	CcSEcCtD
Riluzole—Asthenia—Cisplatin—testicular cancer	0.000148	0.000404	CcSEcCtD
Riluzole—Pharyngitis—Epirubicin—testicular cancer	0.000148	0.000404	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—testicular cancer	0.000148	0.000404	CcSEcCtD
Riluzole—Sweating—Doxorubicin—testicular cancer	0.000147	0.000403	CcSEcCtD
Riluzole—Urinary tract disorder—Epirubicin—testicular cancer	0.000147	0.000402	CcSEcCtD
Riluzole—Oedema peripheral—Epirubicin—testicular cancer	0.000147	0.000401	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—testicular cancer	0.000147	0.0004	CcSEcCtD
Riluzole—Connective tissue disorder—Epirubicin—testicular cancer	0.000147	0.0004	CcSEcCtD
Riluzole—Urethral disorder—Epirubicin—testicular cancer	0.000146	0.000399	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000145	0.000397	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—testicular cancer	0.000145	0.000396	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—testicular cancer	0.000145	0.000395	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—testicular cancer	0.000144	0.000394	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—testicular cancer	0.000144	0.000393	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—testicular cancer	0.000144	0.000392	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—testicular cancer	0.000143	0.000392	CcSEcCtD
Riluzole—Chills—Methotrexate—testicular cancer	0.000143	0.000391	CcSEcCtD
Riluzole—Nausea—Ifosfamide—testicular cancer	0.000142	0.000388	CcSEcCtD
Riluzole—Diarrhoea—Cisplatin—testicular cancer	0.000141	0.000386	CcSEcCtD
Riluzole—Erythema multiforme—Epirubicin—testicular cancer	0.000141	0.000385	CcSEcCtD
Riluzole—Alopecia—Methotrexate—testicular cancer	0.000141	0.000385	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—testicular cancer	0.000141	0.000384	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—testicular cancer	0.00014	0.000381	CcSEcCtD
Riluzole—Eye disorder—Epirubicin—testicular cancer	0.000139	0.000381	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—testicular cancer	0.000139	0.00038	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—testicular cancer	0.000139	0.000379	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—testicular cancer	0.000139	0.000379	CcSEcCtD
Riluzole—Cardiac disorder—Epirubicin—testicular cancer	0.000138	0.000378	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—testicular cancer	0.000138	0.000378	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—testicular cancer	0.000138	0.000377	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—testicular cancer	0.000138	0.000377	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000137	0.000375	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—testicular cancer	0.000137	0.000374	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000136	0.000372	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—testicular cancer	0.000136	0.000371	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—testicular cancer	0.000136	0.000371	CcSEcCtD
Riluzole—Asthenia—Etoposide—testicular cancer	0.000136	0.00037	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000136	0.00037	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—testicular cancer	0.000135	0.00037	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—testicular cancer	0.000135	0.00037	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—testicular cancer	0.000135	0.000368	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—testicular cancer	0.000134	0.000367	CcSEcCtD
Riluzole—Back pain—Methotrexate—testicular cancer	0.000134	0.000367	CcSEcCtD
Riluzole—Chills—Epirubicin—testicular cancer	0.000134	0.000366	CcSEcCtD
Riluzole—Pruritus—Etoposide—testicular cancer	0.000134	0.000365	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—testicular cancer	0.000133	0.000364	CcSEcCtD
Riluzole—Alopecia—Epirubicin—testicular cancer	0.000132	0.00036	CcSEcCtD
Riluzole—Vomiting—Cisplatin—testicular cancer	0.000131	0.000358	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—testicular cancer	0.000131	0.000357	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—testicular cancer	0.00013	0.000356	CcSEcCtD
Riluzole—Rash—Cisplatin—testicular cancer	0.00013	0.000355	CcSEcCtD
Riluzole—Dermatitis—Cisplatin—testicular cancer	0.00013	0.000355	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—testicular cancer	0.00013	0.000355	CcSEcCtD
Riluzole—Diarrhoea—Etoposide—testicular cancer	0.000129	0.000353	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—testicular cancer	0.000129	0.000352	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—testicular cancer	0.000129	0.000352	CcSEcCtD
Riluzole—Anaemia—Methotrexate—testicular cancer	0.000128	0.00035	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—testicular cancer	0.000128	0.00035	CcSEcCtD
Riluzole—Flatulence—Epirubicin—testicular cancer	0.000128	0.000349	CcSEcCtD
Riluzole—Tension—Epirubicin—testicular cancer	0.000127	0.000348	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—testicular cancer	0.000127	0.000347	CcSEcCtD
Riluzole—Nervousness—Epirubicin—testicular cancer	0.000126	0.000344	CcSEcCtD
Riluzole—Back pain—Epirubicin—testicular cancer	0.000126	0.000343	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—testicular cancer	0.000125	0.000342	CcSEcCtD
Riluzole—Malaise—Methotrexate—testicular cancer	0.000125	0.000342	CcSEcCtD
Riluzole—Dizziness—Etoposide—testicular cancer	0.000125	0.000341	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—testicular cancer	0.000125	0.000341	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—testicular cancer	0.000125	0.00034	CcSEcCtD
Riluzole—Vertigo—Methotrexate—testicular cancer	0.000125	0.00034	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000124	0.00034	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—testicular cancer	0.000124	0.000339	CcSEcCtD
Riluzole—Chills—Doxorubicin—testicular cancer	0.000124	0.000338	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—testicular cancer	0.000123	0.000337	CcSEcCtD
Riluzole—Nausea—Cisplatin—testicular cancer	0.000123	0.000335	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—testicular cancer	0.000122	0.000333	CcSEcCtD
Riluzole—Cough—Methotrexate—testicular cancer	0.000121	0.000331	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—testicular cancer	0.000121	0.00033	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—testicular cancer	0.00012	0.000329	CcSEcCtD
Riluzole—Convulsion—Methotrexate—testicular cancer	0.00012	0.000328	CcSEcCtD
Riluzole—Vomiting—Etoposide—testicular cancer	0.00012	0.000328	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—testicular cancer	0.00012	0.000328	CcSEcCtD
Riluzole—Anaemia—Epirubicin—testicular cancer	0.00012	0.000328	CcSEcCtD
Riluzole—Agitation—Epirubicin—testicular cancer	0.000119	0.000326	CcSEcCtD
Riluzole—Rash—Etoposide—testicular cancer	0.000119	0.000326	CcSEcCtD
Riluzole—Dermatitis—Etoposide—testicular cancer	0.000119	0.000325	CcSEcCtD
Riluzole—Headache—Etoposide—testicular cancer	0.000118	0.000323	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—testicular cancer	0.000118	0.000323	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—testicular cancer	0.000118	0.000323	CcSEcCtD
Riluzole—Chest pain—Methotrexate—testicular cancer	0.000118	0.000323	CcSEcCtD
Riluzole—Myalgia—Methotrexate—testicular cancer	0.000118	0.000323	CcSEcCtD
Riluzole—Tension—Doxorubicin—testicular cancer	0.000118	0.000322	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—testicular cancer	0.000118	0.000321	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000117	0.00032	CcSEcCtD
Riluzole—Malaise—Epirubicin—testicular cancer	0.000117	0.00032	CcSEcCtD
Riluzole—Discomfort—Methotrexate—testicular cancer	0.000117	0.000319	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—testicular cancer	0.000117	0.000319	CcSEcCtD
Riluzole—Vertigo—Epirubicin—testicular cancer	0.000117	0.000319	CcSEcCtD
Riluzole—Syncope—Epirubicin—testicular cancer	0.000116	0.000318	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—testicular cancer	0.000116	0.000317	CcSEcCtD
Riluzole—Back pain—Doxorubicin—testicular cancer	0.000116	0.000317	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—testicular cancer	0.000116	0.000315	CcSEcCtD
Riluzole—Palpitations—Epirubicin—testicular cancer	0.000115	0.000313	CcSEcCtD
Riluzole—Confusional state—Methotrexate—testicular cancer	0.000114	0.000312	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—testicular cancer	0.000114	0.000312	CcSEcCtD
Riluzole—Cough—Epirubicin—testicular cancer	0.000113	0.000309	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—testicular cancer	0.000113	0.000309	CcSEcCtD
Riluzole—Convulsion—Epirubicin—testicular cancer	0.000113	0.000307	CcSEcCtD
Riluzole—Infection—Methotrexate—testicular cancer	0.000113	0.000307	CcSEcCtD
Riluzole—Nausea—Etoposide—testicular cancer	0.000112	0.000307	CcSEcCtD
Riluzole—Hypertension—Epirubicin—testicular cancer	0.000112	0.000306	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000111	0.000304	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—testicular cancer	0.000111	0.000303	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—testicular cancer	0.000111	0.000303	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—testicular cancer	0.000111	0.000303	CcSEcCtD
Riluzole—Chest pain—Epirubicin—testicular cancer	0.000111	0.000302	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—testicular cancer	0.000111	0.000302	CcSEcCtD
Riluzole—Myalgia—Epirubicin—testicular cancer	0.000111	0.000302	CcSEcCtD
Riluzole—Agitation—Doxorubicin—testicular cancer	0.00011	0.000302	CcSEcCtD
Riluzole—Anxiety—Epirubicin—testicular cancer	0.00011	0.000301	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—testicular cancer	0.00011	0.0003	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00011	0.0003	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—testicular cancer	0.000109	0.000299	CcSEcCtD
Riluzole—Discomfort—Epirubicin—testicular cancer	0.000109	0.000298	CcSEcCtD
Riluzole—Malaise—Doxorubicin—testicular cancer	0.000108	0.000296	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—testicular cancer	0.000108	0.000295	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—testicular cancer	0.000108	0.000295	CcSEcCtD
Riluzole—Anorexia—Methotrexate—testicular cancer	0.000108	0.000295	CcSEcCtD
Riluzole—Syncope—Doxorubicin—testicular cancer	0.000108	0.000294	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—testicular cancer	0.000108	0.000294	CcSEcCtD
Riluzole—Confusional state—Epirubicin—testicular cancer	0.000107	0.000292	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—testicular cancer	0.000106	0.00029	CcSEcCtD
Riluzole—Oedema—Epirubicin—testicular cancer	0.000106	0.000289	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—testicular cancer	0.000106	0.000289	CcSEcCtD
Riluzole—Hypotension—Methotrexate—testicular cancer	0.000106	0.000289	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—testicular cancer	0.000106	0.000288	CcSEcCtD
Riluzole—Infection—Epirubicin—testicular cancer	0.000105	0.000288	CcSEcCtD
Riluzole—Cough—Doxorubicin—testicular cancer	0.000105	0.000286	CcSEcCtD
Riluzole—Shock—Epirubicin—testicular cancer	0.000104	0.000285	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—testicular cancer	0.000104	0.000284	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—testicular cancer	0.000104	0.000284	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—testicular cancer	0.000104	0.000283	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—testicular cancer	0.000104	0.000283	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—testicular cancer	0.000103	0.000282	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000103	0.000282	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—testicular cancer	0.000103	0.000281	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—testicular cancer	0.000102	0.00028	CcSEcCtD
Riluzole—Insomnia—Methotrexate—testicular cancer	0.000102	0.00028	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—testicular cancer	0.000102	0.000279	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—testicular cancer	0.000102	0.000279	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—testicular cancer	0.000102	0.000279	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—testicular cancer	0.000102	0.000278	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—testicular cancer	0.000102	0.000278	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000102	0.000277	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—testicular cancer	0.000101	0.000276	CcSEcCtD
Riluzole—Anorexia—Epirubicin—testicular cancer	0.000101	0.000276	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—testicular cancer	0.000101	0.000276	CcSEcCtD
Riluzole—Somnolence—Methotrexate—testicular cancer	0.000101	0.000275	CcSEcCtD
Riluzole—Dry mouth—Doxorubicin—testicular cancer	0.0001	0.000273	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—testicular cancer	9.97e-05	0.000272	CcSEcCtD
Riluzole—Hypotension—Epirubicin—testicular cancer	9.9e-05	0.00027	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—testicular cancer	9.89e-05	0.00027	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—testicular cancer	9.84e-05	0.000269	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—testicular cancer	9.81e-05	0.000268	CcSEcCtD
Riluzole—Oedema—Doxorubicin—testicular cancer	9.81e-05	0.000268	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—testicular cancer	9.78e-05	0.000267	CcSEcCtD
Riluzole—Fatigue—Methotrexate—testicular cancer	9.76e-05	0.000267	CcSEcCtD
Riluzole—Infection—Doxorubicin—testicular cancer	9.74e-05	0.000266	CcSEcCtD
Riluzole—Pain—Methotrexate—testicular cancer	9.68e-05	0.000264	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.66e-05	0.000264	CcSEcCtD
Riluzole—Shock—Doxorubicin—testicular cancer	9.65e-05	0.000263	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—testicular cancer	9.62e-05	0.000263	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—testicular cancer	9.6e-05	0.000262	CcSEcCtD
Riluzole—Insomnia—Epirubicin—testicular cancer	9.59e-05	0.000262	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—testicular cancer	9.57e-05	0.000261	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—testicular cancer	9.52e-05	0.00026	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—testicular cancer	9.52e-05	0.00026	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—testicular cancer	9.48e-05	0.000259	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—testicular cancer	9.45e-05	0.000258	CcSEcCtD
Riluzole—Somnolence—Epirubicin—testicular cancer	9.42e-05	0.000257	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—testicular cancer	9.35e-05	0.000255	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—testicular cancer	9.33e-05	0.000255	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—testicular cancer	9.33e-05	0.000255	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—testicular cancer	9.26e-05	0.000253	CcSEcCtD
Riluzole—Decreased appetite—Epirubicin—testicular cancer	9.21e-05	0.000252	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—testicular cancer	9.16e-05	0.00025	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—testicular cancer	9.15e-05	0.00025	CcSEcCtD
Riluzole—Fatigue—Epirubicin—testicular cancer	9.14e-05	0.00025	CcSEcCtD
Riluzole—Constipation—Epirubicin—testicular cancer	9.06e-05	0.000248	CcSEcCtD
Riluzole—Pain—Epirubicin—testicular cancer	9.06e-05	0.000248	CcSEcCtD
Riluzole—Urticaria—Methotrexate—testicular cancer	9e-05	0.000246	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—testicular cancer	8.95e-05	0.000244	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—testicular cancer	8.95e-05	0.000244	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.93e-05	0.000244	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—testicular cancer	8.87e-05	0.000242	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—testicular cancer	8.81e-05	0.00024	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—testicular cancer	8.74e-05	0.000239	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—testicular cancer	8.73e-05	0.000239	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—testicular cancer	8.72e-05	0.000238	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—testicular cancer	8.67e-05	0.000237	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—testicular cancer	8.63e-05	0.000236	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—testicular cancer	8.52e-05	0.000233	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.47e-05	0.000231	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—testicular cancer	8.45e-05	0.000231	CcSEcCtD
Riluzole—Urticaria—Epirubicin—testicular cancer	8.42e-05	0.00023	CcSEcCtD
Riluzole—Pain—Doxorubicin—testicular cancer	8.39e-05	0.000229	CcSEcCtD
Riluzole—Constipation—Doxorubicin—testicular cancer	8.39e-05	0.000229	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—testicular cancer	8.38e-05	0.000229	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—testicular cancer	8.38e-05	0.000229	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—testicular cancer	8.34e-05	0.000228	CcSEcCtD
Riluzole—Asthenia—Methotrexate—testicular cancer	8.12e-05	0.000222	CcSEcCtD
Riluzole—Feeling abnormal—Doxorubicin—testicular cancer	8.08e-05	0.000221	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—testicular cancer	8.02e-05	0.000219	CcSEcCtD
Riluzole—Pruritus—Methotrexate—testicular cancer	8.01e-05	0.000219	CcSEcCtD
Riluzole—Hypersensitivity—Epirubicin—testicular cancer	7.81e-05	0.000213	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—testicular cancer	7.79e-05	0.000213	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—testicular cancer	7.75e-05	0.000212	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—testicular cancer	7.75e-05	0.000212	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—testicular cancer	7.75e-05	0.000212	CcSEcCtD
Riluzole—Asthenia—Epirubicin—testicular cancer	7.6e-05	0.000208	CcSEcCtD
Riluzole—Pruritus—Epirubicin—testicular cancer	7.5e-05	0.000205	CcSEcCtD
Riluzole—Dizziness—Methotrexate—testicular cancer	7.49e-05	0.000205	CcSEcCtD
Riluzole—Diarrhoea—Epirubicin—testicular cancer	7.25e-05	0.000198	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—testicular cancer	7.22e-05	0.000197	CcSEcCtD
Riluzole—Vomiting—Methotrexate—testicular cancer	7.2e-05	0.000197	CcSEcCtD
Riluzole—Rash—Methotrexate—testicular cancer	7.14e-05	0.000195	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—testicular cancer	7.13e-05	0.000195	CcSEcCtD
Riluzole—Headache—Methotrexate—testicular cancer	7.09e-05	0.000194	CcSEcCtD
Riluzole—Asthenia—Doxorubicin—testicular cancer	7.04e-05	0.000192	CcSEcCtD
Riluzole—Dizziness—Epirubicin—testicular cancer	7.01e-05	0.000191	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—testicular cancer	6.94e-05	0.000189	CcSEcCtD
Riluzole—Vomiting—Epirubicin—testicular cancer	6.74e-05	0.000184	CcSEcCtD
Riluzole—Nausea—Methotrexate—testicular cancer	6.73e-05	0.000184	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—testicular cancer	6.71e-05	0.000183	CcSEcCtD
Riluzole—Rash—Epirubicin—testicular cancer	6.68e-05	0.000182	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—testicular cancer	6.68e-05	0.000182	CcSEcCtD
Riluzole—Headache—Epirubicin—testicular cancer	6.64e-05	0.000181	CcSEcCtD
Riluzole—Dizziness—Doxorubicin—testicular cancer	6.48e-05	0.000177	CcSEcCtD
Riluzole—Nausea—Epirubicin—testicular cancer	6.29e-05	0.000172	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—testicular cancer	6.23e-05	0.00017	CcSEcCtD
Riluzole—Rash—Doxorubicin—testicular cancer	6.18e-05	0.000169	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—testicular cancer	6.18e-05	0.000169	CcSEcCtD
Riluzole—Headache—Doxorubicin—testicular cancer	6.14e-05	0.000168	CcSEcCtD
Riluzole—Nausea—Doxorubicin—testicular cancer	5.82e-05	0.000159	CcSEcCtD
